BNET Industries
Last Fiscal Year Sales:$17.5M
- Private
- US
Dow Jones Description
UCB is committed to providing its clients with a wide array of accounts receivable management programs designed to meet and exceed client expectations. UCB is committed to providing a professional and challenging workplace that nurtures both personal and professional growth. UCB is committed to blending state of the art technology with well trained staff to deliver uncompromised customer service.
Number of Employees 174
Peer Companies
NAICS Code Collection Agencies: 561440
Recent Events
-
UCB raises 750 mln euro from bond offer - paper
-
Interim Report - Promising early results for UCB's new products
-
Immunomedics Announces Topline Results For Epratuzumab Phase IIb Study In Systemic Lupus Erythematosus - Quick...
-
Further Topline Results for Epratuzumab Phase IIb Study in Systemic Lupus Erythematosus...
-
Immunomedics Gets a Lot of Things Right
-
UPDATE 4-UCB raises 450 mln euros from convertible bonds
-
UCB, AstraZeneca Agree To Launch Cimzia In Brazil
-
UCB and AstraZeneca partner to market Cimzia in Brazil
-
Abbott bids for Solvay drug unit: source
-
UPDATE 2-Solvay unit bid war looms after Abbott report
-
UCB Selects Cambridge Semantics for Enterprise-Wide Semantic Technology Solution
-
Week of Aug. 24, 2009: Warner Chilcott Buys P&G Pharma Business; Amylin Appoints Former Novartis...
-
Enzyme Fights Mutated Protein in Inherited Parkinson’s Disease
News & Analysis
Filter by
ucb inc. - All News and Analysis
Osmotica Pharmaceutical Corp and Upstate Pharma, LLC, a subsidiary of UCB, Inc., Announce the Availability of Venlafaxine Extended-Release Tablets
- 2008-10-09
WILMINGTON, N.C. -- Osmotica Pharmaceutical Corp. is announcing that Venlafaxine Extended-Release Tablets, 37.5 mg, 75 mg, 150 mg, and 225 mg, which was approved by the U.S. Food and Drug Administration in May, is now commercially available through its marketing partner, Upstate Pharma, LLC, a subsidiary of UCB, Inc. Shipments...
Look who's talking
- 2008-01-01
Since last year, when UCB, Inc. let users of its antiepileptic Keppra speak for the brand, patients have become an important visual and vocal component in all promotion. "These are the people who are heroes," explains Matthew Simonian, UCB group product director. "They're willing to stand up and say, 'I...
Idea exchange exhibitors list
- 2007-06-01
Portfolio Recovery Associates 140 Corporate Boulevard Norfolk, VA 23502 757-961-3531 jlpaulina@portfoliorecovery.com; www.portfoliorecovery.com Portfolio Recovery Associates, Inc., and its subsidiaries purchase, manage, and collect defaulted consumer debt. Since 1996, we have purchased more than $23 billion of delinquent debt. Contingency collections are handled through our...
New Treatment Option for Epilepsy Patients With One of the Most Debilitating Seizure Types
- 2007-03-20
To: MEDICAL EDITORSContact: Andrea Levin of UCB, Inc., +1-770-970-8352, or Andrea.Levin@ucb-group.com ATLANTA, March 20 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration FDA yesterday approved UCB's leading anti- epileptic drug KeppraR levetiracetam tablets and oral solution as adjunctive therapy in the treatment of primary generalized tonic- clonic PGTC seizures in...
Delsym's 12-hour technology gives it an edge
- 2006-06-26
SMYRNA, Ga. -- UCB Inc., the North American subsidiary of UCB S.A., is the marketer of Delsym, the only 12-hour extended-release cough suppressant with a single active ingredient dextromethorphan that is sold over the counter. Delsym, which a spokesman for the company notes is the No. 2 brand in...
- 1
Industry Transcripts by Seeking Alpha
-
Navios Maritime Holdings Inc. Q3 2009 Earnings Call Transcript
on Nov 18, 2009about NM
-
Progressive Corp. Q3 2009 Earnings Call Transcript
on Nov 11, 2009about PGR
-
Nelnet Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NNI
-
American Apparel Q3 2009 Earnings Call Transcript
on Nov 10, 2009about APP
-
MBIA Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about MBI
Glass Door
Financial Services Industry Companies
| Company | Employer Rating |
| Wells Fargo |  |
| U.S. Bank |  |
| Bank of America | |
| Wachovia | |
| JPMorgan Chase | |
IndustryTop Rated
- As Income Mobility Falls, American Dream Fades 7 votes
- Creative Destruction and the new Money Trust 6 votes
- Geithner Deal With Wall Street Over AIG Swaps Cost Taxpayers $13 Billion 4 votes
- Civil Rights Group Teams With Wells Fargo Despite Charges of Predatory Lending 4 votes
- FDIC Chief Sheila Bair to Treasury Brat Geithner: Nyah! 3 votes
